JPH0138088B2 - - Google Patents

Info

Publication number
JPH0138088B2
JPH0138088B2 JP55163447A JP16344780A JPH0138088B2 JP H0138088 B2 JPH0138088 B2 JP H0138088B2 JP 55163447 A JP55163447 A JP 55163447A JP 16344780 A JP16344780 A JP 16344780A JP H0138088 B2 JPH0138088 B2 JP H0138088B2
Authority
JP
Japan
Prior art keywords
compound
formula
treatment
active ingredient
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55163447A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5687522A (en
Inventor
Noiman Peetaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5687522A publication Critical patent/JPS5687522A/ja
Publication of JPH0138088B2 publication Critical patent/JPH0138088B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP16344780A 1979-11-23 1980-11-21 Drug containing dihydropyridine compound Granted JPS5687522A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7940624 1979-11-23

Publications (2)

Publication Number Publication Date
JPS5687522A JPS5687522A (en) 1981-07-16
JPH0138088B2 true JPH0138088B2 (cs) 1989-08-11

Family

ID=10509391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16344780A Granted JPS5687522A (en) 1979-11-23 1980-11-21 Drug containing dihydropyridine compound

Country Status (4)

Country Link
JP (1) JPS5687522A (cs)
AU (1) AU545685B2 (cs)
BE (1) BE886259A (cs)
IT (1) IT1128630B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545075B2 (cs) * 1973-11-29 1980-11-15
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1105477A (en) * 1976-03-22 1981-07-21 Edwin J. Quinn Structurally regulated polyphosphazene copolymers
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
JPS5844066B2 (ja) * 1978-06-16 1983-09-30 釜屋化学工業株式会社 輸液瓶の製造方法

Also Published As

Publication number Publication date
BE886259A (fr) 1981-05-20
IT8050217A0 (it) 1980-11-21
IT1128630B (it) 1986-05-28
AU6460380A (en) 1981-05-28
AU545685B2 (en) 1985-07-25
JPS5687522A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
JP2002520274A (ja) バルサルタンとカルシウムチャンネルブロッカーの抗高血圧組合わせ
JP2004531549A5 (cs)
BG99164A (bg) Антиисхемично лекарствено средство
JP2002537258A5 (cs)
CA2524034A1 (en) Uses of ion channel modulating compounds
JP5680412B2 (ja) レオヌリンの使用およびその組成物
HUE034007T2 (en) Treatment of atrial fibrillation
JP4011114B2 (ja) 脳浮腫抑制剤
US6949548B2 (en) Combination therapy for the treatment of heart failure
HUP9904243A2 (hu) Eljárás a Fas expressziójának gátlására
EP2150253B1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
JP2005506369A (ja) 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用
JPH0138088B2 (cs)
EP0412901B1 (fr) Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale
NL8002041A (nl) Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel.
JP2002541190A (ja) 気分障害治療用医薬を製造するためのオサネタントの使用
EP0968715B1 (en) Loratadine for use as an antiarrhymthmic
JPH0411526B2 (cs)
AU2006252211A1 (en) New association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
JP2003530350A (ja) 外傷性脳損傷及びその他のニューロン障害治療用医薬
EP0303357B1 (en) 4-Amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline for (treatment of cardiac arrhythmias).
US7115604B2 (en) Method for treating erectile dysfunction
CA2533492A1 (en) Use of 3,7-diazabicyclo[3,3,1]nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
JP2949366B2 (ja) 心臓疾患の予防または治療剤
JP2003512328A (ja) レボシメンダンの新規用途